T. Rowe Price Associates’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $100K | Buy |
28,791
+5,351
| +23% | +$18.6K | ﹤0.01% | 2891 |
|
|
2025
Q1 | $50K | Buy |
23,440
+3,748
| +19% | +$8K | ﹤0.01% | 2931 |
|
|
2024
Q4 | $63K | Buy |
19,692
+1,784
| +10% | +$5.71K | ﹤0.01% | 2892 |
|
|
2024
Q3 | $240K | Buy |
17,908
+2,889
| +19% | +$38.7K | ﹤0.01% | 2573 |
|
|
2024
Q2 | $0 | Buy |
+15,019
| New | – | ﹤0.01% | 2943 |
|
|
2022
Q1 | – | Sell |
-6,150
| Closed | -$24K | – | 2976 |
|
|
2021
Q4 | $24K | Hold |
6,150
| – | – | ﹤0.01% | 2952 |
|
|
2021
Q3 | $39K | Hold |
6,150
| – | – | ﹤0.01% | 2907 |
|
|
2021
Q2 | $49K | Hold |
6,150
| – | – | ﹤0.01% | 2893 |
|
|
2021
Q1 | $67K | Buy |
+6,150
| New | +$67K | ﹤0.01% | 2801 |
|